Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-03

COGT vs ERAS: stock comparison and AI forecast

Cogent Biosciences, Inc. (COGT) and Erasca, Inc. (ERAS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

COGT Cogent Biosciences, Inc.

Market Cap
$5.16B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

ERAS Erasca, Inc.

Market Cap
$4.91B
P/E Ratio
–
Size
mid-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

COGT · ERAS

Key facts

  • COGT and ERAS have similar market capitalizations ($5.16B and $4.91B).
  • COGT carries 0.57 times debt per unit of equity, against 0.20 times for ERAS.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricCOGTERAS
Market Cap$5.16B$4.91B
P/B Ratio9.69x13.58x
EPS$-2.15$-0.46
Book Value/Share$3.07$1.03
FCF/Share$-1.78$-0.28

Profitability & Margins

MetricCOGTERAS
ROE-70.8%–
ROA-45.2%–
ROIC-50.2%-75.4%

Financial Health

MetricCOGTERAS
Current Ratio13.57x8.29x
D/E Ratio0.57x0.20x
Financial Leverage1.57x1.20x
Interest Coverage-55.8x–
Working Capital$746M$245M

Cash Flow

MetricCOGTERAS
Operating Cash Flow-$308M-$98M
Free Cash Flow-$309M-$98M
Capital Spending-$2M-$60K

Income Statement

MetricCOGTERAS
Operating Income-$389M-$303M
Net Income-$377M–
R&D Expense$291M$109M

Dividend & Shareholder Information

MetricCOGTERAS
Shares Outstanding174M350M
FAQ

COGT vs ERAS: stock comparison and AI forecast

Which is bigger, COGT or ERAS?

COGT and ERAS have similar market capitalizations ($5.16B and $4.91B).

Which one does Intratio's AI model rank higher, COGT or ERAS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.